AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 12c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.37), $0.12 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $10.55 million versus the consensus estimate of $10.35 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• UBS Reiterates Buy Rating on Smurfit Westrock (SW)
• bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year